Cholesterol, Statins and Colorectal Cancer: A Complex Relationship

New research that suggests high cholesterol is inversely related to colorectal cancer risk has implications for statin use.

Product Spotlight

Injectable Electronic Meshes

A team of Harvard scientists has created 2-by-4-centimeter meshes of silicone nanowires that are so thin and flexible they can be placed in a saline solution, drawn up into a syringe and injected into a living host.

“The meshes rolled up like tiny scrolls...

That’s News

Autism Risk, Cord Blood for IBD and More 

Small Molecules Pack a Big Punch in Colon Cancer Prevention

Promising research may lead to therapies that help prevent colitis-induced cases of colon cancer.

Problem with the Gut? Go with the Mind

A new study suggests that patient participation in brief psycho-educational classes may reduce the severity of symptoms in some patients suffering from irritable bowel syndrome (IBS).

Reimbursement Announcement for Cellvizio Optical Biopsies

Mauna Kea Technologies, leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, announced recently that Cellvizio procedures in the upper GI tract have been added to the Ambulatory Surgical Center (ASC) approved procedure list.

Natural Process in Colon Restrains Tumor Development

A natural safety mechanism in the colon impedes development of adenomas, according to scientists at the Institute for Research in Biomedicine (IRB) in Barcelona, Spain.

New Devices Advance Colon Care

These innovations herald developments in colon cancer detection.

It’s All in the Gut

Microbes in the human gut may prove to be the key to future therapies for much more than gastrointestinal disorders.

Fecal Microbiota Transplant Offers Hope to Immunocompromised Patients

There seemed to be no options. After undergoing an organ transplant, the patient was prescribed high-dose immunosuppressants, which facilitated acceptance of the donated organ but also crippled the patient’s infection-fighting mechanisms. The muted immune response allowed Clostridium difficile (C. diff) bacteria to disrupt the patient’s gut bacterial balance.